Company: SMNR
Filing Date: 2025-08-15
Form Type: 10-Q
Source: 0001213900-25-077047
Chunk: 235

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-15
Form: 10-Q
Item: Part II, Item 5
Chunk 235
---
 report to be signed on its behalf by the undersigned, thereunto duly authorized. 

    Date: August 15, 2025
    DENALI CAPITAL ACQUISITION CORP.

    By: 
    /s/ Lei Huang

    Chief Executive Officer

    (Principal Executive Officer)

    By:
    /s/ You “Patrick” Sun

    Chief Financial Officer

    (Principal Financial and Accounting Officer)

39

NONE
NONE
NONE

http://fasb.org/srt/2025#ChiefExecutiveOfficerMember
0001913577
false
Q2
--12-31

    0001913577

    2025-01-01
    2025-06-30

    0001913577
    
      deca:UnitsEachConsistingOfOneClassAOrdinaryShareAndOneRedeemableWarrantMember

    2025-01-01
    2025-06-30

    0001913577
    
      deca:ClassAOrdinarySharesParValue00001PerShareMember

    2025-01-01
    2025-06-30

    0001913577
    
      deca:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember

    2025-01-01
    2025-06-30

    0001913577
    
      us-gaap:CommonClassAMember

    2025-08-05

    0001913577
    
      us-gaap:CommonClassBMember

    2025-08-05

    0001913577

    2025-06-30

    0001913577

    2024-12-31

    0001913577
    
      us-gaap:RelatedPartyMember

    2025-06-30

    0001913577
    
      us-gaap:RelatedPartyMember

    2024-12-31

    0001913577
    
      us-gaap:CommonClassAMember

    2025-06-30

    0001913577
    
      us-gaap:CommonClassAMember

    2024-12-31

    0001913577
    
      us-gaap:CommonClassBMember